A 12-month phase 3 study of pasireotide in Cushing’s disease - Colao, A; Petersenn, S; Newell-Price, J; Findling, J W; Gu, F; Maldonado, M; Schoenherr, U; Mills, D; Salgado, L R; Biller, B MPasireotide B2305 Study Group (N Engl J Med, 2012)